Search
for
Sort by
Research 331–360 of 1000+
- Hair Follicle Reconstruction and Stem Cells
- An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
- What causes hidradenitis suppurativa ?—15 years after
- Treatment of an alopecia areata patient with tofacitinib results in regrowth of hair and changes in serum and skin biomarkers
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Clinical Perspectives on Alopecia: From Hair Follicle Biology to Advanced Therapies
- Pharmacotherapy of alopecia areata
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Systematic Analysis of Non-coding RNAs Involved in the Angora Rabbit (Oryctolagus cuniculus) Hair Follicle Cycle by RNA Sequencing
- AP-2α/AP-2β transcription factors are key regulators of epidermal homeostasis
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Advances in Understanding Hair Growth
- Endocrine Regulation of Hair Growth and Loss: Current Evidence and Clinical Implications
- TGFβ family mimetic peptide promotes proliferation of human hair follicle dermal papilla cells and hair growth in C57BL/6 mice
- JAK inhibitors in dermatology: The promise of a new drug class
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- ROS-responsive hydrogel-delivered miR-665 targets STAT3 to alleviate inflammation and promote hair follicle regeneration in alopecia areata
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- Short-term Efficacy of Tofacitinib, a JAK Inhibitor, in IFIH1-related Aicardi-Goutières Syndrome
- The development of oral hairy leukoplakia during JAK inhibitor baricitinib therapy
- JAK Inhibitors for Treatment of Alopecia Areata
- 1325 Age-dependent loss of the stemness and antimicrobial defense function of dermal fibroblasts is mediated by TGFbeta
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- JAK inhibition decreases the autoimmune burden in Down syndrome
- JAK inhibition decreases the autoimmune burden in Down syndrome
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies
- JAK inhibition in the treatment of alopecia areata – a promising new dawn?
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology